TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
8.61
-0.03 (-0.35%)
At close: Dec 5, 2025, 4:00 PM EST
8.75
+0.14 (1.63%)
After-hours: Dec 5, 2025, 4:10 PM EST
TransCode Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 5.46 | 5.95 | 7.15 | 8.4 | 3.4 | 0.44 | |
| Research & Development | 11.58 | 9.71 | 12.26 | 10.23 | 2.75 | 0.28 | |
| Operating Expenses | 17.05 | 15.66 | 19.42 | 18.63 | 6.15 | 0.73 | |
| Operating Income | -17.05 | -15.66 | -19.42 | -18.63 | -6.15 | -0.73 | |
| Interest Expense | -0.01 | -0.03 | -0.06 | -0.03 | -0.1 | -0.39 | |
| Interest & Investment Income | 0 | 0 | 0.01 | 0.02 | 0 | 0 | |
| Currency Exchange Gain (Loss) | 0.12 | -0.06 | - | - | - | - | |
| Other Non Operating Income (Expenses) | -10.2 | -1.01 | 0.92 | 1.08 | -0.59 | -1.22 | |
| EBT Excluding Unusual Items | -27.13 | -16.76 | -18.55 | -17.56 | -6.84 | -2.34 | |
| Gain (Loss) on Sale of Assets | 0 | 0 | - | - | -0 | - | |
| Pretax Income | -27.13 | -16.75 | -18.55 | -17.56 | -6.84 | -2.34 | |
| Net Income | -27.13 | -16.75 | -18.55 | -17.56 | -6.84 | -2.34 | |
| Net Income to Common | -27.13 | -16.75 | -18.55 | -17.56 | -6.84 | -2.34 | |
| Shares Outstanding (Basic) | 0 | 0 | - | - | - | - | |
| Shares Outstanding (Diluted) | 0 | 0 | - | - | - | - | |
| EPS (Basic) | -58.12 | -1317.42 | - | - | - | - | |
| EPS (Diluted) | -58.12 | -1317.42 | - | - | - | - | |
| Free Cash Flow | -14.52 | -13.36 | -18.11 | -15.86 | -5.52 | -0.49 | |
| Free Cash Flow Per Share | -31.10 | -1050.30 | - | - | - | - | |
| EBITDA | -17 | -15.57 | -19.3 | -18.54 | -6.11 | - | |
| D&A For EBITDA | 0.04 | 0.09 | 0.12 | 0.1 | 0.04 | - | |
| EBIT | -17.05 | -15.66 | -19.42 | -18.63 | -6.15 | -0.73 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.